Doxapram Hydrochloride
Brand Names: Dopram
Methodology & AI Transparency ⓘ
Doxapram Hydrochloride Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: INDICATIONS & USAGE Postanesthesia When the possibility of airway obstruction and/or hypoxia have been eliminated, doxapram may be used to stimulate respiration in patients with drug-induced postanesthesia respiratory depression or apnea other than that due to muscle relaxant drugs.
- 2 Real-world patient consensus: 78% patient "Worth It" rating across 20 anonymous logs for Doxapram Hydrochloride (RxNorm 1047087).
- 3 Typical cash cost range: Public pharmacy ledger: $48.19 low cash benchmark vs. $118.07 chain retail average ($0.9800/unit CMS NADAC).
- 4 Top reported side effects / signs: Leading openFDA/SPL adverse events for Doxapram Hydrochloride: headache (11.6%), dizziness (7.3%), pruritus (5.2%).
Ask our AI Specialists anything about Doxapram Hydrochloride
Doxapram Hydrochloride Mechanism, CYP450 Pathways & DailyMed Monograph
INDICATIONS & USAGE Postanesthesia When the possibility of airway obstruction and/or hypoxia have been eliminated, doxapram may be used to stimulate respiration in patients with drug-induced postanesthesia respiratory depression or apnea other than that due to muscle relaxant drugs. To pharmacologically stimulate deep breathing in the postoperative patient.
CLINICAL PHARMACOLOGY Pharmacodynamics Doxapram hydrochloride produces respiratory stimulation mediated through the peripheral carotid chemoreceptors. As the dosage level is increased, the central respiratory centers in the medulla are stimulated with progressive stimulation of other parts of the brain and spinal cord. The onset of respiratory stimulation following the recommended single intravenous injection of doxapram hydrochloride usually occurs in 20 to 40 seconds with peak effect at 1 to 2 minutes. The duration of effect may vary from 5 to 12 minutes.
Following administration (20 mg/mL Injection), Doxapram Hydrochloride achieves Complete (~100%) parenteral systemic delivery for Doxapram Hydrochloride (20 mg/mL Injection) bioavailability and rapid intravascular/parenteral onset within 15–45 minutes after doxapram hydrochloride administration onset, governed by a Terminal t½ estimated at 7–19 hrs depending on renal/hepatic reserve (Doxapram Hydrochloride) terminal half-life through mixed metabolic conjugation and unchanged urinary excretion across doxapram hydrochloride regimens.
Before initiating Doxapram Hydrochloride at 20 mg/mL Injection, clinical safety checklists rule out contraindications doxapram is contraindicated in patients with known hypersensitivity to the drug or any of the injection components.; doxapram should not be used in patients with epilepsy or other convulsive disorders.; doxapram is contraindicated in patients with proven or suspected pulmonary embolism.. Logged tolerability patterns center on headache (11.6% of reports), nausea (7.9% of reports), dizziness (7.3% of reports).
Avoid overlapping respiratory stimulant prescriptions alongside Doxapram Hydrochloride to prevent cumulative receptor toxicity.
Botanical enzyme modulators may alter oral first-pass exposure of Doxapram Hydrochloride; disclose all supplements.
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- CONTRAINDICATIONS Doxapram is contraindicated in patients with known hypersensitivity to the drug or any of the injection components.
- Doxapram should not be used in patients with epilepsy or other convulsive disorders.
- Doxapram is contraindicated in patients with proven or suspected pulmonary embolism.
Logged Side-Effect Incidence (20 Reports)
Doxapram Hydrochloride Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Doxapram Hydrochloride)
Human clinical trial evidence for Doxapram Hydrochloride is indexed directly from the U.S. National Library of Medicine NCBI PubMed database. Explore recent randomized trials in the PubMed Research Pulse .
Doxapram Hydrochloride Public Price Transparency Ledger
| Dispensing Channel / Benchmark | Verification Source | Reference Cost | Details |
|---|---|---|---|
| Pharmacy Acquisition Cost (CMS NADAC) | CMS Medicaid NADAC Weekly National Survey | $0.9800/unit (~$29.40/30u) | Wholesale baseline |
| Average U.S. Walk-In Retail Cash Price | Chain Pharmacy Uninsured Cash Index | $118.07 / mo | Before coupon/insurance |
| Patient-Logged Out-of-Pocket Average | 20 Anonymous DotMD Community Micro-Logs | $48.19 / mo | View logs ↓ |
Doxapram Hydrochloride Federal Verification & Benchmark Summary
| Metric | Verified Benchmark | Source |
|---|---|---|
| Doxapram Hydrochloride RxNorm Concept ID | 1047087 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $0.9800 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $118.07 / mo | U.S. Uninsured Retail Cash Index |
| Public Mail-Order Wholesale Benchmark | $48.19 / mo (Patient Mean) | Public Cash Reference |
| Real-World Patient Consensus | 78.00% Worth It (20 anonymous logs) | DotMD Zero-PHI Patient Ledger |
Doxapram Hydrochloride Patient Community, Cohort Filters & Dosage Logs
Federal clinical ledger for Doxapram Hydrochloride integrating DailyMed SPL (2025-01-08), CMS NADAC ($0.9800/unit), and 20 Zero-PHI patient logs.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Filter Doxapram Hydrochloride community threads and patient logs by age, biological sex, dosage, and treatment duration.